Bracco Diagnostics gains FDA approval for updated CardioGen-82 infusion system

Michael Walter | | Cardiovascular Business | Cardiac Imaging
approved approval

Bracco Diagnostics announced Friday, Oct. 16, that its new CardioGen-82 infusion system for cardiac PET myocardial perfusion imaging (MPI) has received FDA approval.

This new infusion system, which replaces the company’s current offering, was designed to “provide easy access to all system components” while keeping radiation exposure to a minimum. It also includes features focused on decreasing manual record keeping and changing protocol details as needed.

“The new infusion system exemplifies Bracco's significant investment in the cardiac PET imaging modality and is the culmination of thoughtful design and feedback from healthcare providers,” Vittorio Puppo, president and CEO of Bracco Diagnostics, said in a prepared statement.

“Cardiac PET MPI with the CardioGen-82 generator has helped accurately diagnose thousands of patients since 1989,” added Kim McDaniel, senior director of nuclear medicine sales and market support for Bracco Diagnostics. “Bracco was the first company to heavily invest in the modality for the diagnosis of coronary artery disease, and our introduction of the new infusion system is one more example of our commitment to our customers and patients worldwide.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Angiographic catheters recalled due to safety risk
AMA agrees to help after initial request for an independent cardiovascular board was denied
AI model gets helpful heart assessments out of nongated CT scans
Late-breaking clinical trials announced for New York Valves 2025
FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging
Cardiac imaging pioneer remembered for his joy and enthusiasm

Around the web

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business
U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.